Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MDUFMA Branding Provision Reprieve To Be Explained In Upcoming Guidance

This article was originally published in The Gray Sheet

Executive Summary

FDA will give manufacturers 18 months to implement branding provisions of the Medical Device User Fee & Modernization Act upon issuance of a final guidance explaining how firms may achieve compliance

You may also be interested in...



MDUFMA Guidance Forecast: E-Labeling, Appeals, GMP Inspections

Legal concerns raised by FDA's Office of Chief Counsel likely will delay issuance of a planned Sec. 301 guidance, according to MDUFMA Implementation Director Joanne Less, PhD

MDUFMA Guidance Forecast: E-Labeling, Appeals, GMP Inspections

Legal concerns raised by FDA's Office of Chief Counsel likely will delay issuance of a planned Sec. 301 guidance, according to MDUFMA Implementation Director Joanne Less, PhD

Reprocessed SUD Recall Underlines Sec. 301 Branding Concerns – OEMs

A recent recall by reprocessor MedSurg Solutions could spur FDA to change its format for recall notices

Related Content

UsernamePublicRestriction

Register

OM006664

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel